Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use

NM Blebea, AI Pricopie, RA Vlad, G Hancu - International Journal of …, 2024 - mdpi.com
Phytocannabinoids, a diverse group of naturally occurring compounds extracted from the
Cannabis plant, have attracted interest due to their potential pharmacological effects and …

Cannabinoids in the treatment of selected mental illnesses: Practical approach and overview of the literature

KR Müller-Vahl - Pharmacopsychiatry, 2024 - thieme-connect.com
Although an increasing number of patients suffering from mental illnesses self-medicate with
cannabis, current knowledge about the efficacy and safety of cannabis-based medicine in …

[HTML][HTML] Oxycodone Self-Administration in Female Rats is Enhanced by∆ 9-tetrahydrocannabinol, but not by Cannabidiol, in a Progressive Ratio Procedure

JD Nguyen, Y Grant, C Yang, A Gutierrez, MA Taffe - bioRxiv, 2023 - ncbi.nlm.nih.gov
Epidemiological evidence suggests that the legalization of cannabis may reduce opioid-
related harms. Preclinical evidence of neuropharmacological interactions of endogenous …

[PDF][PDF] The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysis

J Wilson, A Langcake, Z Bryant, TP Freeman, J Leung… - 2024 - scholar.archive.org
There has been a global increase in the use of cannabinoids as a treatment for mental
health (MH) and substance use disorders (SUD). In 2016, an Australian government-funded …

[PDF][PDF] BJP PRE-PROOF (article published as accepted)

J de Jesus Mari, F Kapczinski, AR Brunoni, A Gadelha… - researchgate.net
This is the second part of the Brazilian S20 mental health report. The mental health working
group is dedicated to leveraging scientific insights to foster innovation and propose …